Latest News about NVS
Recent news which mentions NVS
2 Unstoppable Green Flags for AbbVie
April 14, 2022
From Motley Fool
Biogen’s Aduhelm Crashes the Biotech Sector
April 13, 2022
From InvestorPlace
From Benzinga
Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?
April 12, 2022
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
April 11, 2022
From Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
From Benzinga
3 Things About Pfizer That Smart Investors Know
April 08, 2022
From Motley Fool
From InvestorPlace
From Benzinga
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
April 05, 2022
Tickers
NVS
From Benzinga
From Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
April 05, 2022
From InvestorPlace
From Benzinga
Novartis To Strengthen Pipeline, Boost Productivity With New Organizational Structure
April 04, 2022
Tickers
NVS
From Benzinga
From Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
From InvestorPlace
From Benzinga
From Motley Fool
Novartis Receives Positive CHMP Opinion For Kymriah In Follicular Lymphoma, Jakavi In GvHD
March 25, 2022
Tickers
NVS
From Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
March 24, 2022
From Motley Fool
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
March 24, 2022
From Benzinga
FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer
March 24, 2022
Tickers
NVS
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.